IRCT20200411047019N1招募中3 期
Investigating the Effect of BCG Vaccine on Preventing COVID-19 Infection in Healthcare Staff Exposed to SARS-CoV-2
Professor Alborzi Clinical Microbiology Research Center, Shiraz University of Mdical Sciences0 个研究点目标入组 500 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Healthcare workers potentially exposed to patient with COVID-19 infection in hospitals
- •Over 18 years of age
- •Complete the consent form with date and signature
- •Male and female
排除标准
- •Allergy to the BCG vaccine or any BCG vaccine contraindication
- •Fever (>38 C) within the past 24 hours or generalised skin diseases such as infection, eczema, dermatitis or psoriasis at or near the site of vaccination.
- •Cases with active or latent Mycobacterium tuberculosis
- •Known HIV infection
- •Individuals with any serious underlying illness (such as malignancy) except those with cardiovascular disease, hypertension, diabetes, and/or chronic respiratory disease if they are not immunocompromised
- •Live vaccine administered for 4 weeks prior to randomization
- •Suspected to active viral or bacterial infections
- •Individuals with a SARS-CoV-2 positive test result
- •Severely immunocompromised subject or who has taken immunosuppressive therapy in the last years
研究者
相似试验
进行中（未招募）
不适用
Effect of BCG vaccination for tuberculosis on COVID-19 in BrazilCOVID-19 (SARS-CoV-2 infection) in persons who were previously given the BCG vaccineInfections and InfestationsISRCTN47802196ational Council for Scientific and Technological Development200,805
进行中（未招募）
不适用
BCG vaccination against COVID-19CTRI/2020/06/025854Indian Council of Medical Research
进行中（未招募）
1 期
Safety and effectivity of BCG vaccination against controlled human malaria infectioPlasmodium faciparum malaria preventionMedDRA version: 18.1Level: LLTClassification code 10036655Term: Prevention of malariaSystem Organ Class: 100000004865MedDRA version: 18.1Level: PTClassification code 10025487Term: MalariaSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 18.1Level: LLTClassification code 10016171Term: Falciparum malariaSystem Organ Class: 10021881 - Infections and infestationsEUCTR2015-005735-40-NLRadboud university medical center
已完成
2 期
Safety and protective efficacy of BCG vaccination against controlled human malaria infectioPlasmodium falciparum10037072malariaNL-OMON43394Radboud Universitair Medisch Centrum20
招募中
2 期
Effect of BCG in treatment of diabetes type 1IRCT20201012049003N1Yazd University of Medical Sciences16